Our in vitro and in vivo results indicated that inhibiting Nrf2/ARE signaling pathway by overexpressing SNAI3-AS1 dramatically enhanced erastin-induced ferroptosis in glioma and suppressed tumor growth accordingly. The gene discussed is NFE2L2; the disease is central nervous system cancer.